================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2000 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ...... to ...... Commission file number 0-19654 - -------------------------------------------------------------------------------- VITESSE SEMICONDUCTOR CORPORATION (Exact name of registrant as specified in its charter) - -------------------------------------------------------------------------------- Delaware 77-0138960 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 741 Calle Plano Camarillo, CA 93012 (Address of principal executive offices) (805) 388-3700 (Registrant's telephone number, including area code) ----------------------- Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days: Yes (X) No ( ). As of April 28, 2000, there were 164,520,989 shares of $0.01 par value common stock outstanding. ================================================================================ VITESSE SEMICONDUCTOR CORPORATION TABLE OF CONTENTS ----------------- Page Number PART I FINANCIAL INFORMATION Item 1 Financial Statements: Condensed Consolidated Balance Sheets as of March 31, 2000 2 (unaudited) and September 30, 1999 Unaudited Condensed Consolidated Statements of Operations for 3 the Three Months ended March 31, 2000, March 31, 1999 and December 31, 1999 and the Six Months ended March 31, 2000 and March 31, 1999 Unaudited Condensed Consolidated Statements of Cash Flows for 4 the Six Months ended March 31, 2000 and March 31, 1999 Notes to Unaudited Condensed Consolidated Financial Statements 6 Item 2 Management's Discussion and Analysis of 8 Financial Condition and Results of Operations Item 3 Quantitative and Qualitative Disclosure About Market Risk 16 PART II OTHER INFORMATION Item 2 Changes in Securities 17 Item 4 Submission of Matters to a Vote of Security Holders 17 Item 6 Exhibits and Reports on Form 8-K 18 1 PART I FINANCIAL INFORMATION VITESSE SEMICONDUCTOR CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share data) March 31, 2000 Sept. 30, 1999 -------------- -------------- (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 33,359 $ 81,912 Short-term investments 615,916 107,245 Accounts receivable, net 88,294 69,034 Inventories, net 33,509 26,931 Prepaid expenses 16,384 5,462 Deferred tax assets, net 48,902 26,918 ---------- -------- Total current assets 836,364 317,502 ---------- -------- Long-term investments 295,712 38,063 Property and equipment, net 100,044 78,723 Restricted long-term deposits 76,057 67,334 Intangible assets, net 460,587 14,609 Deferred tax assets, net 6,237 6,237 Other assets 18,072 425 ---------- -------- $1,793,073 $522,893 ========== ======== LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 8,616 $ 15,118 Accrued expenses and other current liabilities 24,460 12,832 Income taxes payable 5,122 5,517 Current portion of long-term debt 1,852 2,013 ---------- -------- Total current liabilities 40,050 35,480 ---------- -------- Long-term debt 1,371 725 Convertible subordinated debt 720,000 - Minority interest 697 - Shareholders' equity: Common stock, $.01 par value. Authorized 500,000,000 shares; issued and outstanding 164,299,059 and 156,176,636 shares on March 31, 2000 and Sept. 30, 1999, respectively 1,642 1,561 Additional paid-in capital 919,197 380,035 Retained earnings 110,116 105,092 ---------- -------- Total shareholders' equity 1,030,955 486,688 ---------- -------- $1,793,073 $522,893 ========== ======== See accompanying Notes to Condensed Consolidated Financial Statements. 2 VITESSE SEMICONDUCTOR CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (in thousands, except per share data) Three Months Ended Six Months Ended ---------------------------------------------- ----------------------------- Mar. 31, 2000 Mar. 31, 1999 Dec. 31, 1999 Mar. 31, 2000 Mar. 31, 1999 -------------- ------------- ------------- ------------- ------------- Revenues $100,167 $ 66,937 $ 89,223 $189,390 $127,645 Costs and expenses: Cost of revenues 34,995 25,009 31,624 66,619 48,234 Engineering, research & development 17,166 12,210 14,920 32,086 23,162 Selling, general & administrative 11,387 9,100 10,195 21,582 16,948 Purchased in-process research & development 45,614 - - 45,614 - -------- -------- -------- -------- -------- Total costs & expenses 109,162 46,319 56,739 165,901 88,344 -------- -------- -------- -------- -------- Income (loss) from operations (8,995) 20,618 32,484 23,489 39,301 Other income, net 3,683 2,768 2,794 6,477 5,249 -------- -------- -------- -------- -------- Income (loss) before income taxes (5,312) 23,386 35,278 29,966 44,550 Income taxes 13,300 7,868 11,642 24,942 14,428 -------- -------- -------- -------- -------- Net income (loss) $(18,612) $ 15,518 $ 23,636 $ 5,024 $ 30,122 ======== ======== ======== ======== ======== Net income (loss) per share Basic $(0.12) $0.10 $0.15 $0.03 $0.20 ======== ======== ======== ======== ======== Diluted $(0.12) $0.09 $0.14 $0.03 $0.18 ======== ======== ======== ======== ======== Shares used in per share computations: Basic 158,711 151,918 156,753 157,767 151,588 ======== ======== ======== ======== ======== Diluted 158,711 165,880 169,845 171,058 165,630 ======== ======== ======== ======== ======== See accompanying Notes to Condensed Consolidated Financial Statements. 3 VITESSE SEMICONDUCTOR CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in thousands) Six Months Ended ------------------------------- Mar. 31, 2000 Mar. 31, 1999 -------------- -------------- Cash flows from operating activities: Net income $ 5,024 $ 30,122 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 14,033 10,535 Interest expense on debt issue costs 158 -- Amortization of debt discount 178 -- Purchased in-process research & development 45,614 -- Change in assets and liabilities: (Increase) decrease in, net of effects of acquisition: Accounts receivable, net (19,250) (7,675) Inventories (6,578) (3,584) Prepaid expenses (10,818) (1,754) Other assets 200 (5,335) Increase (decrease) in, net of effects of acquisition: Accounts payable (6,586) 282 Accrued expenses and other current liabilities (7,870) 3,445 Income taxes payable 24,547 11,408 --------- -------- Net cash provided by operating activities 38,652 37,444 --------- -------- Cash flows from investing activities: Investments, net (766,320) 3,740 Capital expenditures (33,086) (18,897) Restricted long-term deposits (8,723) 1,594 Cash acquired in business combination 991 (12,816) --------- -------- Net cash used in investing activities (807,138) (26,379) --------- -------- Cash flows from financing activities: Principal payments under long-term debt (2,008) (464) Proceeds from issuance of convertible subordinated debt 720,000 -- Cash paid for debt issue costs (18,000) -- Capital contributions by minority interest limited partners 697 -- Elimination of duplicate period of pooled companies - 834 Proceeds from issuance of common stock 19,244 13,322 --------- -------- Net cash provided by financing activities 719,933 13,692 --------- -------- Net increase (decrease) in cash and cash equivalents (48,553) 24,757 Cash and cash equivalents at beginning of period 81,912 76,963 --------- -------- Cash and cash equivalents at end of period $ 33,359 $101,720 ========= ======== See accompanying Notes to Condensed Consolidated Financial Statements. 4 VITESSE SEMICONDUCTOR CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in thousands) Six Months Ended -------------------------------- Mar. 31, 2000 Mar. 31, 1999 ---------------- ------------- Supplemental disclosures of cash flow information: Cash paid during the period for: Interest $ -- $ 7 ======== ======= Income taxes $ 256 $ 1,582 ======== ======= Supplemental disclosures of non-cash transactions: Issuance of stock options in purchase transaction $ 50,531 $ 300 ======== ======= Issuance of common stock in purchase transaction $422,542 $ -- ======== ======= Issuance of notes payable in purchase transaction $ -- $ 2,725 ======== ======= Increase in equity associated with tax benefit from exercise of stock options $ 46,926 $22,643 ======== ======= See accompanying Notes to Condensed Consolidated Financial Statements. 5 VITESSE SEMICONDUCTOR CORPORATION NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Note 1. Basis of Presentation and Significant Accounting Policies The accompanying condensed consolidated financial statements are unaudited and include the accounts of Vitesse Semiconductor Corporation and its subsidiaries (the "Company"). All intercompany accounts and transactions have been eliminated. In management's opinion, all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of financial condition and results of operations are reflected in the attached interim financial statements. This report should be read in conjunction with the audited financial statements presented in the 1999 Annual Report. Footnotes and other disclosures which would substantially duplicate the disclosures in the Company's audited financial statements for fiscal year 1999 contained in the Annual Report have been omitted. The interim financial information herein is not necessarily representative of the results to be expected for any subsequent period. Computation of Net Income per Share The reconciliation of shares used to calculate basic and diluted income per share consists of the following (in thousands): Three Months Ended Six Months Ended --------------------------------------------- ----------------------------- Mar. 31, 2000 Mar. 31, 1999 Dec. 31, 2000 Mar. 31, 2000 Mar. 31, 1999 ------------- ------------- ------------- ------------- ------------- Shares used in basic per share computations - weighted average shares outstanding 158,711 151,918 156,753 157,767 151,588 Net effect of dilutive common share equivalents based on treasury stock method -- 13,962 13,092 13,291 14,042 ------- ------- ------- ------- ------- Shares used in diluted per share computations 158,711 165,880 169,845 171,058 165,630 ======= ======= ======= ======= ======= Common stock equivalents to purchase 283,102 shares that were outstanding at March 31, 1999, were not included in the computation of diluted net income per share, as their effect would have been antidilutive. Common stock equivalents to purchase 19,685,685 shares that were outstanding at March 31, 2000, were not included in the computation of diluted net income per share for the quarter ended March 31, 2000, because, due to the net loss position, the effect would be antidilutive. Comprehensive Income On October 1, 1998 the Company adopted Statement of Financial Accounting Standards No. 130, "Reporting Comprehensive Income." This statement establishes standards for reporting and display of comprehensive income and its components in a full set of general-purpose financial statements. The Company has no components of other comprehensive income. Therefore comprehensive income is the same as reported net income. 6 Segment Reporting On October 1, 1998 the Company adopted Statement of Financial Accounting Standards No. 131, "Disclosures about Segments of an Enterprise and Related Information." This statement establishes standards for reporting operating segment information in annual financial statements and interim reports issued to shareholders. The Company operates in only one segment, as defined by SFAS No. 133. Substantially all long-lived assets are located in the United States. Reclassifications and Restatements Where necessary, prior periods' information has been reclassified to conform to the current period condensed consolidated financial statement presentation. On September 13, 1999, the Board of Directors approved a 2 for 1 stock split of the Company's Common Stock that was effected on October 20, 1999. All references to the number of common shares, weighted average number of common shares and per share data for all periods presented have been adjusted to reflect the stock split. Note 2. Inventories, net Inventories consist of the following (in thousands): March 31, 2000 September 30, 1999 -------------- ------------------ Raw materials $ 6,258 $ 5,168 Work in process and finished goods 27,251 21,763 ------- ------- $33,509 $26,931 ======= ======= Note 3. Long Term Debt During March 2000, the Company completed a private offering of $720 million of 4% convertible subordinated debentures due 2005. Net proceeds received by the Company, after costs of issuance, were approximately $702 million. Interest is payable in arrears semiannually on March 15 and September 15 of each year, beginning September 15, 2000. The debentures are convertible into the Company's common stock at $112.19 per share, subject to certain adjustments. The notes may be redeemed, at the Company's option, on or after March 15, 2003 at specified redemption prices. For the quarter ended March 31, 2000, interest expense relating to the convertible subordinated debentures aggregated $1.4 million. Note 4. Business Combinations On March 31, 2000, the Company acquired all of the equity interests of Orologic, Inc. ("Orologic") in exchange for 4,546,883 shares of common stock and stock options to purchase 543,815 shares of common stock valued, in the aggregate, at approximately $490 million, which 7 includes estimated direct acquisition costs of $17 million. Orologic is a "fabless" semiconductor company that develops high performance system on a chip solutions that enable data packet processing at OC-48 and OC-192 rates. The acquisition of Orologic was recorded using the purchase method of accounting. Therefore, the consideration was allocated based upon the relative fair values of the tangible and intangible assets and liabilities acquired. The allocation includes purchased in-process research and development of $45.6 million, which has been charged to expense in the three month period ended March 31, 2000, identifiable intangibles of $813,000, and excess consideration of $446 million recorded as goodwill. Goodwill and the other identifiable intangibles will be amortized over their estimated useful lives ranging from 2 to 6 years. Pro forma consolidated results of operations for the six month period ended March 31, 2000 and 1999 are summarized below to reflect the acquisition of Orologic as if it had occurred on October 1, 1999 and 1998, respectively: Six months ended March 31, (in thousands except per share data) 2000 1999 - ---------------------------------------------------------------------- Revenues $189,640 127,705 Net loss (36,872) (7,518) Net loss per share - basic and diluted (0.23) (0.05) Note 5. Subsequent Event In April 2000, the Company agreed to acquire all of the equity interests of SiTera, Inc. (SiTera) in exchange for $750 million of the Company's common stock. SiTera is a provider of Intelligent Network Processing for service provider, carrier edge and large enterprise markets. The transaction is expected to be completed in the quarter ending June 30, 2000. The Company expects the transaction to be accounted for as a pooling-of-interests; however, pooling-of-interests accounting is not a condition to closing. Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations The information set forth in "Management's Discussion and Analysis of Financial Condition and Results of Operations" below includes "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), in particular, in "Results of Operations-- Orologic Acquisition and Income Taxes," and in "Liquidity and Capital Resources- - -Investing and Financing Activities," and is subject to the safe harbor created by that section. Factors that management believes could cause results to differ materially from those projected in the forward looking statements are set forth below in "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Factors That May Affect Future Operating Results." 8 Results of Operations Revenues Total revenues in the second quarter of fiscal 2000 were $100.2 million, a 50% increase over the $66.9 million recorded in the second quarter of fiscal 1999 and a 12% increase over the $89.2 million recorded in the prior quarter. For the six months ended March 31, 2000, total revenues were $189.4 million, a 48% over the $127.6 million recorded in the six months ended March 31, 1999. The increase in total revenues was due to unit growth in shipments of existing products, as well as the introduction of new products to customers in the communications market. Cost of Revenues Cost of revenues as a percentage of total revenues in the second quarter of fiscal 2000 was 34.9% compared to 37.4% in the second quarter of fiscal 1999 and 35.4% in the prior quarter. The decrease in cost of revenues as a percentage of total revenues resulted primarily from a reduction in per unit costs associated with increased utilization of the Company's Colorado Springs wafer fabrication facility, as well as improved manufacturing yields during the first and second quarters of fiscal 2000. Engineering, Research and Development Costs Engineering, research and development expenses were $17.2 million in the second quarter of fiscal 2000 compared to $12.2 million in the second quarter of fiscal 1999 and $14.9 million in the prior quarter. For the six months ended March 31, 2000, engineering, research, and development costs were $32.1 million compared to $23.2 million in the six month period ended March 31, 1999. The increases were principally due to increased headcount and higher costs to support the Company's continuing efforts to develop new products. As a percentage of total revenues, engineering, research and development costs were 17.1% in the second quarter of fiscal 2000, 18.2% in the second quarter of fiscal 1999, and 16.7% in the prior quarter. For the six months ended March 31, 2000, engineering, research and development costs as a percentage of total revenues decreased to 16.9% from 18.1%, in the comparable period a year ago. The Company expects these costs to continue to increase as a result of continued efforts to develop new products and increased headcount related to recent acquisitions. The Company's engineering, research and development costs are expensed as incurred. Selling, General and Administrative Expenses Selling, general and administrative expenses (SG&A) were $11.4 million in the second quarter of 2000, compared to $9.1 million in the second quarter of 1999 and $10.2 million in the prior quarter. For the six months ended March 31, 2000, SG&A expenses were $21.6 million compared to $16.9 million in the same period in fiscal 1999. The increase was due principally to increased headcount and higher commissions earned by sales representatives resulting from increased sales. As a percentage of total revenues, SG&A expenses were 11.4% in the second quarter of 2000, compared to 13.6% in the second quarter of 1999 and 11.3% in the prior quarter. For the six months ended March 31, 2000, SG&A expenses as a percentage of total revenues 9 decreased to 11.4% from 13.3%, in the comparable period a year ago. The Company expects these costs to continue to increase as a result of expected future growth. Orologic Acquisition In connection with the acquisition of Orologic, the Company recorded a second quarter fiscal 2000 charge of $45.6 million for the fair value of purchased in- process research and development ("IPR&D"). In addition, $446 million was allocated to identifiable intangible assets and goodwill. Such assets are being amortized over their expected lives, ranging from 2 to 6 years, increasing annual and quarterly amortization expense by approximately $74.5 million and $18.6 million, respectively. The fair values allocated to the intangible assets acquired, including the IPR&D, were based upon independent appraisals. Other Income, Net Other income consists of interest income, net of interest and other expenses. Other income increased to $3.7 million in the second quarter of fiscal 2000 from $2.8 million in the second quarter of 1999 and the prior quarter. For the six months ended March 31, 2000, other income increased to $6.5 million from $5.2 million in the comparable period a year ago. The increase is due to higher average cash, short-term investments, long-term investments and long-term deposit balances resulting from increased profitability and proceeds received from the convertible debenture offering. This was slightly offset with increased interest expense relating to the debentures and amortization of debt issuance costs. As a result of the convertible debenture offering, the Company expects to record additional interest expense of approximately $7.2 million per quarter in future periods. Income Taxes The Company's year to date effective income tax rate is 83.2 % as of March 31, 2000 compared to 34% for the same period in the prior year. For the quarter ended March 31, 2000, the effective income tax rate is (250%) compared to 34% for the quarter ending March 31, 1999. Excluding the effects of the Orologic transaction, the quarter and year to date effective income tax rates are approximately 33% through March 31, 2000. Liquidity and Capital Resources Operating Activities The Company generated $38.7 million and $37.4 million from operating activities in the six months ended March 31, 2000 and 1999, respectively. The increase in cash flow from operations was principally due to an improvement in profitability, excluding the one time non-cash charge of $45.6 million relating to purchased in-process research and development. 10 Investing Activities The Company used $807.1 million and $26.4 million in investing activities during the six months ended March 31, 2000 and 1999, respectively. The increase in cash used in investing activities was primarily due to the net investment of $766.3 million, in held to maturity debt and equity securities, from the proceeds received from the private placement offering. Capital expenditures, principally for manufacturing and test equipment, were $33.1 million in the six months ended March 31, 2000 compared to $18.9 million in the six months ended March 31, 1999. The Company intends to continue investing in manufacturing, test and engineering equipment. The Company entered into an operating lease transaction providing for the financing of $11.1 million for the acquisition of certain test equipment. Payments under this lease commenced in November 1999. If at the end of the lease term the Company does not purchase the property, the Company would guarantee the residual value to the lessor equal to a specified percentage of the lessor's cost of the equipment. As of March 31, 2000, the lessor advanced a total of $11.1 million under this lease and had held $8.8 million as cash collateral, which amount is included in restricted long-term deposits. Financing Activities The Company's financing activities provided $719.9 million for the six months ended March 31, 2000, representing proceeds, net of issuance costs, of $702 million received from the convertible subordinated debentures offering and proceeds of $19.2 million received from the issuance and sale of common stock pursuant to the Company's stock option and stock purchase plans. Management believes that the Company's cash and cash equivalents, short-tem investments, and cash flow from operations are adequate to finance its planned growth and operating needs for the next 12 months. Impact of Recent Accounting Pronouncements In June 1998, the Financial Accounting Standards Board issued SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities." SFAS No. 133 will require recognition of all derivatives as either assets or liabilities on the balance sheet at fair value. The Company will adopt SFAS No. 133, as amended by SFAS No. 137, in the first quarter of its fiscal year ending September 30, 2001. Management has not completed an evaluation of the effects this standard will have on the Company's consolidated financial statements. In December 1999, the Securities and Exchange Commission issued Staff Accounting Bulletin (SAB) No. 101, "Revenue Recognition in Financial Statements." The objective of this SAB is to provide further guidance on revenue recognition issues in the absence of authoritative literature addressing a specific arrangement or a specific industry. The Company is required to follow the guidance in the SAB no later than the first quarter of its year 2001. The SEC has recently indicated it intends to issue further guidance with respect to adoption of specific issues addressed by SAB No. 101. Until such time as this additional guidance is issued, the Company is unable to assess the impact, if any, it may have, however based on current guidance the Company believes adoption of the SAB will not have a material impact on the Company's financial position or results of operations. In March 2000, the Financial Accounting Standards Board issued FASB Interpretation No. 44, "Accounting for Certain Transactions involving Stock Compensation" (FIN 44). FIN 44 provides guidance for issues arising in applying APB Opinion No. 25, "Accounting for Stock Issued to Employees". FIN 44 applies specifically to new awards, exchanges of awards in a business combination, modification to outstanding awards, and changes in grantee status that occur on or after July 1, 2000, except for the provisions related to repricings and the definition of an employee which apply to awards issued after December 15, 1998. Application of FIN 44 did not have an effect on the Company's financial reporting. 11 Factors That May Affect Future Operating Results We are Dependent on a Small Number of Customers in a Few Industries We intend to continue focusing our sales effort on a small number of customers in the communications and test equipment markets that require high- performance integrated circuits. Some of these customers are also our competitors. For the six months ended March 31, 2000, our three largest customer accounted for 16%, 15% and 11% of our total revenues and no other customer accounted for more than 10% of our total revenues. If any of our major customers delays orders of our products or stops buying our products, our business and financial condition would be severely affected. Our Operating Results May Fluctuate Our quarterly revenues and expenses may fluctuate in the future. These variations may be due to a number of factors, many of which are outside our control. Factors that could affect our future operating results include the following: . The loss of major customers . Variations, delays or cancellations of orders and shipments of our products . Reduction in the selling prices of our products . Significant changes in the type and mix of products being sold . Delays in introducing new products . Design changes made by our customers . Our failure to manufacture and ship products on time . Changes in manufacturing capacity, the utilization of this capacity and manufacturing yields . Variations in product and process development costs . Changes in inventory levels; and . Expenses or operational disruptions resulting from acquisitions In the past, we have recorded significant new product and process development costs because our policy is to expense these costs at the time that they are incurred. We may incur these types of expenses in the future. In future periods, we expect a substantial increase in amortization of intangibles assets resulting from recent acquisitions and interest expense resulting from recent financing activities. These additional expenses will have a material and adverse effect on our earnings in future periods. The occurrence of any of the above mentioned factors could have a material adverse effect on our business and on our financial results. We Have Limited Manufacturing Capacity and We Depend on a New Production Facility During 1998, we started producing high-performance integrated circuits at our new six-inch wafer fabrication factory in Colorado Springs, Colorado. We are faced with several risks in the 12 successful operation of this facility as well as in our overall production operations. We had only produced finished four-inch wafers until 1998 and therefore we have limited experience with the equipment and processes involved in producing finished six-inch wafers. We do not have excess production capacity at our Camarillo plant to offset failure of the new Colorado facility to meet production goals. Further, some of our products have been qualified for manufacture at only one of the two facilities. Consequently, our failure to successfully operate the new facility could severely damage financial results. We also must now effectively coordinate and manage two facilities. We have limited experience in managing production facilities located at two different sites, and our failure to successfully do so could have a material adverse effect on our business and operating results. There Are Risks Associated with Recent and Future Acquisitions In fiscal 1999, we made four strategic acquisitions. In March 2000, we completed the acquisition of Orologic, Inc., in exchange for approximately 4.6 million shares of our common stock. In April 2000, we agreed to acquire SiTera, Inc., for approximately $750 million of our common stock, and we expect to complete the acquisition in the quarter ending June 30, 2000. These acquisitions may result in the diversion of management's attention from the day- to-day operations of the Company's business. Risks of making these acquisitions include difficulties in the integration of acquired operations, products and personnel. If we fail in our efforts to integrate recent and future acquisitions, our business and operating results could be materially and adversely affected. In addition, acquisitions we will make could result in dilutive issuances of equity securities, substantial debt, and amortization expenses related to goodwill and other intangible assets. In particular, in connection with our acquisition of Orologic, Inc., we were required to record acquisition related expenses of $45.6 million in the three months ended March 31, 2000. Further, we expect to amortize an aggregate of approximately $446 million of goodwill and other identifiable intangible assets over the next 2 to 6 years. In addition, we presently expect to account for our acquisition of SiTera, Inc., as a pooling-of-interests, however, this accounting treatment is not a condition for the completion of the acquisition. If we are required to account for the acquisition of SiTera, Inc., under the purchase method of accounting, we would be required to record additional acquisition related expenses and amortization expense related to intangible assets acquired. We do not have any binding obligations with respect to any particular acquisition; however, our management frequently evaluates strategic opportunities available. In the future we may pursue additional acquisitions of complementary products, technologies or businesses. Our Industry Is Highly Competitive The high-performance semiconductor market is extremely competitive and is characterized by rapid technological change, price erosion and increased international competition. The communications and test equipment industries, which are our primary target markets, are also becoming intensely competitive because of deregulation and international competition. We compete directly or indirectly with the following categories of companies: 13 . Gallium Arsenide fabrication operations of systems companies such as Conexant and Fujitsu . High-performance silicon integrated circuit manufacturers who use Emitter Coupled Logic ("ECL"), Bipolar Complementary Metal-Oxide-Semiconductor ("BiCMOS") or Complementary Metal-Oxide-Semiconductor ("CMOS") technologies such as Hewlett Packard, Fujitsu, Motorola, Lucent Technologies, Texas Instruments and Applied Micro Circuits Corporation . Internal integrated circuit manufacturing units of systems companies such as Lucent Technologies, Siemens and Fujitsu Our current and prospective competitors include many large companies that have substantially greater marketing, financial, technical and manufacturing resources than we do. Competition in the markets that we serve is primarily based on price/performance, product quality and the ability to deliver products in a timely fashion. Product qualification is typically a lengthy process and some prospective customers may be unwilling to invest the time or expense necessary to qualify suppliers such as Vitesse. Prospective customers may also have concerns about the relative advantages of our products compared to more familiar silicon-based semiconductors. Further, customers may also be concerned about relying on a relatively small company for a critical sole-sourced component. To the extent we fail to overcome these challenges, there could be material and adverse effects on our business and financial results. There is Risk Associated with Doing Business in Foreign Countries In fiscal 1999, international sales accounted for 33% of our total revenues, and we expect international sales to constitute a substantial portion of our total revenues for the foreseeable future. International sales involve a variety of risks and uncertainties, including risks related to: . Reliance on strategic alliance partners . Compliance with foreign regulatory requirements . Variability of foreign economic conditions . Changing restrictions imposed by U.S. export laws, and . Competition from U.S. based companies that have firmly established significant international operations Failure to successfully address these risks and uncertainties could adversely affect our international sales, which could in turn have a material and adverse effect on our results of operations and financial condition. We Must Keep Pace with Product and Process Development and Technological Change The market for our products is characterized by rapid changes in both product and process technologies. We believe that our success to a large extent depends on our ability to continue to improve our product and process technologies and to develop new products and technologies in 14 order to maintain our competitive position. Further, we must adapt our products and processes to technological changes and adopt emerging industry standards. Our failure to accomplish any of the above could have a negative impact on our business and financial results. We Are Dependent on Key Suppliers We manufacture our products using a variety of components procured from third-party suppliers. Most of our high-performance integrated circuits are packaged by third parties. Other components and materials used in our manufacturing process are available from only a limited number of sources. Any difficulty in obtaining sole- or limited-sourced parts or services from third parties could affect our ability to meet scheduled product deliveries to customers. This in turn could have a material adverse effect on our customer relationships, business and financial results. Our Manufacturing Yields Are Subject to Fluctuation Semiconductor fabrication is a highly complex and precise process. Defects in masks, impurities, in the materials used, contamination of the manufacturing environment and equipment failures can cause a large percentage of wafers or die to be rejected. Manufacturing yields vary among products, depending a particular high-performance integrated circuit's complexity and on our experience in manufacturing it. In the past, we have experienced difficulties in achieving acceptable yields on some high-performance integrated circuits, which has led to shipment delays. Our overall yields are lower than yields obtained in a mature silicon process because we manufacture a large number of different products in limited volume and our process technology is less developed. We anticipate that many of our current and future products may never be produced in volume. Since a majority of our manufacturing costs are relatively fixed, maintaining a number of shippable die per wafer is critical to our operating results. Yield decreases can result in higher unit costs and may lead to reduced gross profit and net income. We use estimated yields for valuing work-in-process inventory. If actual yields are material different than these estimates, we may need to revalue work-in-process inventory. Consequently, if any of our current or future products experience yield problems, our financial results may be adversely affected. Our Business Is Subject to Environmental Regulations We are subject to various governmental regulations related to toxic, volatile and other hazardous chemicals used in our manufacturing process. Our failure to comply with these regulations could result in the imposition of fines or in the suspension or cessation of our operations. Additionally, we may be restricted in our ability to expand operations at our present locations or we may be required to incur significant expenses to comply with these regulations. Our Failure to Manage Growth May Adversely Affect Us The management of our growth requires qualified personnel, systems and other resources. In particular, the continued operation of the new facility in Colorado Springs and its integration with the Camarillo facility will require significant management, technical and administrative 15 resources. Additionally, we have recently established several product design centers worldwide. Finally, we acquired Vermont Scientific Technologies, Inc. ("VTEK") in November 1998, Serano Systems Corporation ("Serano") in January 1999, XaQti Corporation ("XaQti") in July 1999, and Orologic, Inc. ("Orologic") in March 2000, and agreed to acquire SiTera, Inc. ("SiTera") in April 2000, and have only limited experience in integrating the operations of acquired businesses. Failure to manage our growth or to successfully integrate new and future facilities or newly acquired businesses could have a material adverse effect on our business and financial results. We Are Dependent on Key Personnel Due to the specialized nature of our business, our success depends in part upon attracting and retaining the services of qualified managerial and technical personnel. The competition for qualified personnel is intense. The loss of any of our key employees or the failure to hire additional skilled technical personnel could have a material adverse effect on our business and financial results. Item 3. Quantitative and Qualitative Disclosure About Market Risk At March 31, 2000, the Company's long-term debt consists of convertible subordinated debentures with interest at a fixed rate. Consequently, the Company does not have significant cash flow exposure on its long-term debt. However, the fair value of the convertible subordinated debentures is subject to significant fluctuation due to their convertibility into shares of Vitesse common stock. 16 PART II OTHER INFORMATION Item 2. Changes in Securities In March 2000, we issued 4,546,883 shares of our common stock and assumed stock options to purchase 543,815 shares of our common stock, in connection with the acquisition of all the equity interests of Orologic, Inc. The issuance of shares and assumption of stock options were made pursuant to the exemption from registration provided by Section 4(2) of the Securities Act of 1933, as amended, based on the limited number of securities holders of Orologic, the relationship of such security holders to Orologic, and the lack of any advertisement or general solicitation in connection with the acquisition. In March 2000, we issued $720 million in aggregate principal amount of our 4% convertible subordinated debentures, due 2005. Net proceeds to Vitesse of this offering, after costs of issuance, were approximately $702 million. The debentures are convertible into the Company's common stock at $112.19 per share, subject to certain adjustments. The initial purchasers of our debentures were Lehman Brothers Inc., Goldman, Sachs & Co. and Prudential Securities Incorporated. The debentures were issued pursuant to the exemption from registration provided for by Section 4(2) of the Securities Act of 1933, as amended. Item 4. Submission of Matters to a Vote of Security Holders On January 25, 2000, the Company held its regular Annual Meeting of Stockholders. The purpose of the meeting was to elect Directors to serve for the ensuing year, to approve an amendment to the Directors' Stock Option Plan to reserve an additional 250,000 shares of Vitesse common stock thereunder for issuance, to approve a proposal to amend the Company's Amended and Restated Certificate of Incorporation to provide for an increase in the authorized shares of common stock, par value $0.01 per share, of the Company, from 250,000,000 to 500,000,000 and to ratify the appointment of KPMG LLP as independent auditors for the Company for the 2000 fiscal year. The following individuals were elected to serve as Directors for the ensuing year: Name Age Principal Occupation ---- --- -------------------- Pierre R. Lamond 69 General Partner of Sequoia Capital and Chairman of the Board of Directors of the Company James A. Cole 57 General Partner of Windward Ventures and Spectra Enterprise Associates Alex Daly 38 President and Chief Executive Officer of Cygnus Solutions John C. Lewis 64 Chairman of Amdahl Corporation Louis R. Tomasetta 51 President, Chief Executive Officer and Director of the Company 17 Additionally, the following items were voted upon and approved by the shareholders: Against or Votes Votes for Withheld Abstained ----------- ---------- --------- Approval of an amendment to the Directors' Stock Option Plan to reserve an additional 250,000 shares of Vitesse common stock thereunder for issuance 97,979,964 36,880,772 283,498 Approval of a proposal to amend the Company's Amended and Restated Certificate of Incorporation to provide for an increase in authorized shares of common stock, par value $0.01 per share, of the Company, from 250,000,000 to 500,000,000 126,519,952 8,479,076 145,206 Ratification of appointment of KPMG LLP as independent auditors for the fiscal year ending September 30, 2000 134,946,799 68,881 128,554 Item 6. Exhibits & Reports on Form 8-K (a) Exhibits 2.1 Agreement and Plan of Merger and Reorganization, entered into as of March 24, 2000, by and among Vitesse Semiconductor Corp., Holiday Acquisition Corp., and Orologic, Inc., incorporated by reference to Current Report on Form 8-K dated March 31, 2000. 3.1 Restated Certificate of Incorporation of Vitesse Semiconductor Corp., filed herewith. 4.1 Indenture, dated as of March 7, 2000, between the Company and Lehman Brothers Inc., Goldman, Sachs & Co. and Prudential Securities Incorporated, including the form of the Company's 4% Convertible Subordinated Notes Due 2005, filed herewith. 4.2 Registration Rights Agreement, dated as of March 13, 2000, between the Company and Lehman Brothers Inc., Goldman, Sachs & Co. and Prudential Securities Incorporated, filed herewith. 27 Financial Data Schedule. (b) Reports on Form 8-K Report on Form 8-K, dated March 6, 2000, reporting the announcement of the anticipated offering of $600,000,000 in aggregate principal amount of convertible subordinated debentures due 2005 in a private placement transaction. 18 Report on Form 8-K, dated March 13, 2000, reporting the completion of the offering of $600,000,000 in aggregate principal amount of 4% Convertible Subordinated Debentures due 2005 in a private placement transaction. Report on Form 8-K, dated March 24, 2000, reporting the Company's agreement to acquire all of the equity interest of Orologic, Inc. Report on Form 8-K, dated March 31, 2000, reporting the completion of the Company's acquisition of all the equity interests of Orologic, Inc. Report on Form 8-K, dated March 31, 2000, reporting the completion of an offering of an additional $120,000,000 in aggregate principal amount of 4% Convertible Subordinated Debentures due 2005 in a private placement transaction pursuant to the exercise by the initial purchasers of their over-allotment option. Report on Form 8-K, dated April 19, 2000, reporting the Company's agreement to acquire all of the equity interest of SiTera, Inc. 19 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. VITESSE SEMICONDUCTOR CORPORATION May 15, 2000 By: /s/Eugene F. Hovanec -------------------- Eugene F. Hovanec Vice President, Finance and Chief Financial Officer 20 INDEX TO EXHIBITS 3.1 Restated Certificate of Incorporation of Vitesse Semiconductor Corp. 4.1 Indenture 4.2 Registration Rights Agreement 27 Financial Data Schedule 21